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Abstract
Background: Post amputation, the complication of phantom limb pain (PLP) is prevalent and difficult to manage.
This study aimed to determine whether it was feasible and acceptable to undertake a definitive multicentred
randomised controlled trial assessing the effectiveness of acupuncture for treating lower limb amputees with PLP.
Methods: A mixed-methods embedded design, including a randomised controlled trial and semistructured interviews,
was undertaken. A total of 15 participants with PLP were randomly assigned to receive either eight pragmatic Traditional
Chinese Medicine acupuncture treatments and usual care or usual care alone over 4 weeks. Outcome measures were
completed at baseline, weekly throughout the study and at 1 month post completion of the study and included:
a numerical pain-rating scale, the Short-Form McGill Pain Questionnaire 2, the EQ-5D-5 L, the Hospital Anxiety
and Depression Scale, the Perceived Stress Scale 10-item, the Insomnia Severity Index, and the Patient Global
Impression of Change. Post completion of the trial, participants in the acupuncture group were interviewed
about their experience. Feasibility-specific data were also collected.
Results: Of 24 amputees meeting the study inclusion criteria, 15 agreed to participate (recruitment rate 62.50 %).
Qualitatively, acupuncture was perceived to be beneficial and effective. Quantitatively, acupuncture demonstrated
clinically meaningful change in average pain intensity (raw change = 2.69) and worst pain intensity (raw change = 4.00).
Feasibility-specific data identified that before undertaking a definitive trial, recruitment, practitioner adherence to the
acupuncture protocol, completion of outcome measures at 1 month follow-up and blinding should be addressed.
Appropriate outcome measures were identified for use in a definitive trial. Data were generated for future sample size
calculations (effect size 0.64). Allowing for a 20 % dropout rate, a sample size of 85 participants per group would be
needed in a future definitive trial.
Conclusions: A future definitive trial may be possible if the areas identified in this study are addressed. As acupuncture
may be effective at treating PLP, and as this feasibility study suggests that a definitive trial may be possible, a
multicentred trial with adequate sample size and blinding is now needed.
Trial registration: ClinicalTrials.gov Identifier: NCT02126436, registered on 4 September 2014.
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Background
Phantom limb pain (PLP) is defined as painful sensations
in the missing portion of the amputated limb. It is
neuropathic in nature and caused by a lesion of the som-
atosensory nervous system [1]. It may be chronic and
has been found to influence individuals’ subjective well-
being, affecting both physical and mental components of
quality of life [2].
Currently, PLP is not well-managed. A systematic re-
view evaluating the use of preemptive analgesia found that
only one case-controlled study supported using combined
bupivacaine, diamorphine, and clonidine. Epidural and
perineural infusions containing local anaesthetic with or
without opiates were deemed only effective for treating
acute perioperative pain [3]. A small randomised con-
trolled trial found that intravenous ketamine could signifi-
cantly reduce PLP during, and for 30 mins after, infusion
[4]. However, a subsequent systematic review found it to
be ineffective [5]. The most commonly used first-line
treatment is gabapentin [6] but a systematic review
found this to be beneficial for short-term analgesic effi-
cacy only [7]. Many case studies report positively on
the effectiveness of mirror therapy [8] but few rando-
mised controlled trials have been completed and ad-
verse effects have been reported.
Acupuncture has been found to be effective for treat-
ing a variety of chronic pain conditions [9] but little
quality evidence is available on the use of acupuncture
for PLP. A recent systematic review identified only two
nonrandomised controlled trials [10] and 26 case studies
[11]. Further research is needed to evaluate the effective-
ness of acupuncture for treating PLP, but prior to a de-
finitive trial a study is needed to inform on feasibility.
This study aimed to evaluate the feasibility and accept-
ability of completing a small randomised controlled trial in
preparation for a definitive multicentred randomised con-
trolled trial [12]. Objectives were to: (1) explore the feasi-
bility of recruiting, randomising, and retaining participants,
(2) evaluate the feasibility and acceptability of having a
usual care control, (3) evaluate adherence/compliance and
acceptability of acupuncture as an intervention, (4) evalu-
ate the appropriateness of outcome measures, (5) identify
appropriate primary and secondary outcome measures
which could be used in future trials, (6) explore the
perceived effectiveness of acupuncture for treating PLP,
(7) generate data on effect size for use in future sample
size calculations, and (8) inform the development of an
appropriate and feasible protocol for use in a definitive
multicentred randomised controlled trial.
Methods
A comparative effectiveness study using a mixed-methods
embedded design, including a small randomised con-
trolled trial incorporating semistructured interviews, was
undertaken. The randomised controlled trial was unstrati-
fied, open, pragmatic, with two parallel arms, balanced
randomisation and a usual care control. Interviews were
cross-sectional. The study protocol has been published
[12]. The trial was registered with ClinicalTrials.gov
(NCT02126436). A Consolidated Standards of Reporting
Trials (CONSORT) checklist is included within the arti-
cle’s additional files (Additional file 1, CONSORT 2010
checklist of information to include when reporting a ran-
domised trial.pdf). Ethical approval was granted from the
NRES Committee London – Bloomsbury (14/LO/0817)
and London South Bank University; the trial commenced
in October 2014 and closed 1 year later in October 2015.
Participants were recruited from an NHS inpatient
amputee rehabilitation unit in London. All participants
were provided with information and were required to
consent orally and in writing. Participants were included
if they were: (1) 18 years of age or above, (2) had full
cognitive ability and were able to communicate in Eng-
lish, (3) had had traumatic or medical amputation of a
lower limb (more than just toes), and (4) were currently
experiencing worst PLP of ≥5 on an 11-point verbal rat-
ing scale. Participants were excluded if they: (1) had con-
genital limb absence, (2) were medically unwell, (3) were
pregnant, and (4) if acupuncture use was cautioned [13].
Participants were randomly allocated to either receive
usual care and acupuncture or usual care alone. A usual
care comparator was chosen as the study was undertaken
under the Medical Research Council guidelines for devel-
oping and evaluating complex interventions. Usual care
included pharmacological medical intervention, physio-
therapy, and occupational therapy. Acupuncture was pro-
vided by an NHS clinic colocated in the same building by
one British Acupuncture Council-registered acupuncture
practitioner (BSc (Hons) Acupuncture) with more than
15 years of clinical experience. Acupuncture was delivered
pragmatically under the Traditional Chinese Medicine
(TCM) paradigm. A protocol developed prior to the study,
using Delphi consensus methodology was used to provide
guidelines [14] and included:
 Using a combination of body and auricular
acupuncture
 Treating the contralateral limb and possibly the
ipsilateral limb
 Including auricular acupuncture points such as
the Shen Men and the sympathetic and points
corresponding to the lower limb
 Depending on the health of the tissue and the
individual participant, needling around the stump
 Mirroring local and distal points by needling the
opposite limb
 Including points on the lower back (taking a
segmental approach to dermatomal pain)
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 Including points such as LI4 + LR3, LR3, GV20,
SP10, and also specified points according to
participants’ specific symptoms
 Attempting to obtain deqi
 Retaining needles for 20–30 min
Treatment could include electroacupuncture or other ad-
junctive interventions including cupping, exercises, and life-
style advice. All participants in the acupuncture group were
allocated eight 1-h sessions (twice weekly for 4 weeks).
Outcome measures were completed at baseline, weekly
for the duration of the trial and 1 month post comple-
tion of the study. The primary outcome measure was an
11-point numerical rating scale (NRS) capturing average
PLP over the past week, using the anchors 0 meaning ‘no
pain’ and 10 meaning ‘pain as bad as you can imagine’
[15]. Secondary outcome measures included; NRS captur-
ing worst PLP over the past week, the Short Form McGill
Pain Questionnaire 2 (SF-MPQ-2) [16], the EuroQol-5 di-
mensions, 5 levels (EQ-5D-5 L) questionnaire [17], the
Hospital Anxiety and Depression Scale (HADS) [18], the
Perceived Stress Scale 10-item (PSS-10) [19], the Insomnia
Severity Index (ISI) [20], and a 7-point Patient Global Im-
pression of Change (PGIC) scale ranging from 1 meaning
‘no change’ to 7 meaning ‘a great deal better’. Phrasing of
the PGIC question was similar to the phrasing used by
Hurst and Bolton [21] and stated ‘since being enrolled in
this study how would you describe the change (if any) in
activity limitations, symptoms, emotion, and overall
quality of life in relation to your phantom limb pain?’
Feasibility-specific data were collected (Table 4) and post
completion of the study, participants in the acupuncture
group were interviewed. Interviews were conducted by
the researcher who enrolled participants and collected
outcome measures. Interviews were semistructured,
audio-recorded, followed a topic guide and were tran-
scribed verbatim.
No sample size calculation was undertaken but a sam-
ple of 20 was deemed adequate to inform on feasibility
[22]. Interim safety and effectiveness were not formally
evaluated but data were collected through participant in-
terviews. Randomisation and allocation concealment was
undertaken by a researcher not involved in the study
using a computer-generated random numbers table.
Randomisation was unstratified and balanced using a
block size of 4 and allocation concealment was imple-
mented using sequentially numbered opaque envelopes
which were only opened once participants had been en-
rolled. The researcher collecting outcome measures and
analysing the data enrolled the participants and was
blinded to their allocation. Participants and acupuncture
practitioners were not blinded.
Quantitative data analysis used an intention-to-treat
approach and missing data were imputed using last
observation carried forward. The intervention was dis-
continued after week 4 and this was chosen as the pri-
mary endpoint of the study (day 28). As this was a
feasibility study no significance tests were performed
and no hypothesis testing is reported. Raw change, the
difference between mean baseline and subsequent scores
was calculated for the NRS and considered meaningful/
clinically significant when ≥1.80 [23]. Cohen’s d effect
size was calculated using the calculation:
d ¼ M1–M2=σ;
where M =mean and σ = standard deviation, pooled
using Cohen’s criteria: 0.2, small effect; 0.5, medium ef-
fect; and 0.8, large effect [24]. Framework Analysis [25]
was used to analyse qualitative data. Specific steps were
followed during data analysis including: familiarisation,
coding, identifying an analytical framework, indexing,
charting, and mapping/interpretation. All codes and
themes were developed inductively during analysis of the
data. Inferences were drawn from analysis of qualitative
and quantitative findings. Meta-inferences were drawn
through combining qualitative and quantitative findings
using side-by-side comparison [26].
Using effect size data generated from this study and tak-
ing the assumption that a future study would: (1) use an
11-point NRS measuring average pain over the last week,
(2) have normally distributed data, (3) use a two-tailed
independent samples T test to compare acupuncture ver-
sus usual care, and (4) set power and level of significance/
α-level at 0.8 and 0.05, respectively, enabling a sample size
for a future definitive trial to be calculated [27]:
n ¼ 2ðZa þ Z1−βÞ2σ2;
Δ2
where, Za = 1.96 [27], Z1-β = 0.8416 [27], σ = standard
deviation (estimated) and Δ = estimated effect size.
Results
A total of 36 lower limb amputees were identified of whom
12 were ineligible. Of those eligible 9 refused to participate.
A total of 15 participants were enrolled and their data were
analysed within their originally assigned groups. Before the
primary endpoint two were withdrawn due to being medic-
ally unwell and one dropped out having been randomised
to usual care. A total of 12 participants completed out-
comes at day 28, the primary endpoint of the study (seven
in the acupuncture group and five in the usual care group).
A total of 10 participants did not complete the 1-month
follow-up questionnaire and 2 participants refused to be
interviewed at the end of the study (Fig. 1).
Demographic details are presented in Table 1. Between
groups there were differences in gender. In the acupunc-
ture group six were men and in the usual care group five
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were women. In the acupuncture group the majority of
participants were below-knee amputees, whereas in the
usual care group the majority were above-knee ampu-
tees. Baseline primary and secondary outcome measure
scores were similar between groups.
Quantitative findings
In the acupuncture group mean average pain decreased
from 5.44 to 2.75 and in the usual care group from 5.43
to 4.43 (Fig. 2). In the acupuncture group decrease in
average pain was found to be clinically meaningful (raw
change = 2.69), but not in the usual care group (raw
change = 1.00). At day 28, a medium effect was found
between groups (d = 0.64).
In the acupuncture group decrease in mean worst pain
was found to be clinically meaningful (raw change = 4.00)
but this was not so in the usual care group (raw
change = 1.00). The SF-MPQ-2 identified a small effect
between groups at day 28 (d = 0.46). Mean HADS anx-
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Fig. 1 Participant flow through the trial
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the study in both groups (score ≤7). As with the
HADS, little change was observed in PSS-10 scores
over the course of the study. Both groups at baseline
had subthreshold insomnia (ISI score 8–14) which im-
proved by day 28. Throughout the study EQ-5D-5 L
scores were stable across dimensions. At the primary
endpoint of the study the PGIC identified that partici-
pants in the acupuncture group rated themselves as
‘better’ whereas participants in the usual care group
rated themselves as ‘a little better’. The datasets sup-
porting these findings are included in Table 2.
Qualitative findings
Six themes were identified through interviews with par-
ticipants who received acupuncture (Table 3). Partici-
pants were initially sceptical and apprehensive about
being involved in the trial, had low expectations of acu-
puncture and hoped to be randomised to usual care.
However, these views changed; participants liked treat-
ment (even if it was not physically needed) and found it
relaxing. Electroacupuncture was considered beneficial
and pleasant and receiving two treatments a week was
considered acceptable though some participants found
this tiring. Acupuncture was perceived to be effective at
resolving or reducing PLP and other health problems
and four to six treatments were needed for it to be ef-
fective. Acupuncture was not perceived to cause any ad-
verse effects. The environment where the acupuncture
was conducted was considered to affect the effectiveness
of treatment.
Completing outcome measures was considered accept-
able and relevant, but the SF-MPQ-2 included words
which some participants did not understand. Length of
time and frequency of questionnaire completion was
acceptable with only one participant thinking that they
were given too often. Overall, being involved in the
study was considered a good experience and acupunc-
ture was perceived to be beneficial. Participant quotes
are included in Table 3.
Feasibility-specific findings
Recruitment was problematic, clinicians sometimes
failed to identify suitable participants, the unit did not
always run at full capacity and potential participants
were often unwilling to be involved having just had a
major amputation. Of those identified, 12 were ineligible
for inclusion, mainly due to PLP being less than 5/10 in
intensity and of the remainder n = 24, 62.50 % consented
to be enrolled. Randomisation worked well with only
one participant dropping out due to being randomised
to usual care and all participants were treated in the
group they were allocated into. Those enrolled reported
being happy to be randomised to either acupuncture or
usual care. Blinding was unsuccessful, with both partici-
pants and practitioners unintentionally informing the re-
searcher which group they had been allocated to.
Participant compliance to the protocol was good [14].
The four participant deviations were due to: tiredness,
forgetting appointments, appointments coinciding with
another medical appointment, and not wanting further
treatment as PLP had resolved. Practitioner adherence
to the protocol was poor and no participant received all
Table 1 Participant demographics




Age mean (±95 % CI) 51.63 (40.38–62.87) 55.71 (40.17–71.26)
Gender n (%)
Male 6 (75.00) 2 (28.57)
Female 2 (25.00 ) 5 (71.43)
Ethnicity n (%)
White British 7 (87.50) 4 (57.14)
Black Caribbean 1 (12.50) 1 (14.29)
Black African 0 (0.00) 1 (14.29)
White other 0 (0.00 ) 1 (14.29)
Employment status n (%)
Student 0 (0.00) 1 (14.29)
Unemployed 1 (12.50) 0 (0.00)
Sick leave 5 (62.50) 3 (42.86)
Retired 2 (25.00) 3 (42.86)
Time since amputation in
days mean (±95 % CI)
25.63 (18.43–32.85) 29.43 (13.12–45.74)
Level of amputation n (%)
Above-knee 2 (25.00 ) 4 (57.14)
Below-knee 6 (75.00) 3 (42.86)
Reason for amputation n (%)
Vascular 5 (62.50) 3 (42.86)
Trauma 2 (25.00) 2 (28.57)
Infection 0 (0.00) 1 (14.29)
Other 1 (12.50) 1 (14.29)
History of past amputations? n (%)
Yes 2 (25.00) 1 (14.29)
No 6 (75.00) 6 (85.71)
General health n (%)
Diabetes I 1 (12.50) 0 (0.00)
Diabetes II 3 (37.50) 2 (28.57)
Cancer 1 (12.50) 0 (0.00)
Osteoarthritis 1 (12.50) 0 (0.00)
Epilepsy 1 (12.50) 0 (0.00)
Nil 1 (12.50) 5 (71.43)
Mobility level n (%)
Wheelchair user 8 (100.00) 7 (100.00)
CI confidence interval
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eight treatments (mean total number of treatments 5.14
(4.02–6.27)). Despite the protocol [14] advising using a
combination of auricular and body acupuncture this was
only given to one participant on two occasions. Both
lower limbs were treated 66.67 % of the time whereas
for the contralateral limb this was only 8.33 %. Needle
retention time and adverse events were not reported.
For the dataset on acupuncture points used by prac-
titioners in this feasibility study, see Additional file 2
(Acupuncture points used by practitioners during the
feasibility study.pdf).
Outcome measures were identified which would be
appropriate for a definitive trial. The NRS, SF-MPQ-2,
and PGIC captured change. Baseline HADS scores were
normal and little change was observed in the PSS-10
and the EQ-5D-5 L suggesting that these outcomes may
be inappropriate. The ISI may not be appropriate in an
inpatient setting as anecdotally noise and medication af-
fected sleep. Retention of participants up until the pri-
mary endpoint of the study was good, but at 1-month
follow-up was poor.
A sample size for a future trial was calculated corre-
sponding to an effect size of 0.64 and pooled standard
deviation of 1.36. A total of 71 per group (142 in total)
would be needed. According to findings from this feasi-
bility study, the follow-up rate at 4 weeks was 80 %.
Therefore, considering a 20 % dropout rate, 170 partici-
pants (85 per group) are recommended to detect a
significant change in a two-armed, parallel-group rando-
mised controlled trial comparing acupuncture and usual
care as measured using an 11-point NRS measuring
average pain at 4 weeks.
Using the criteria set a priori [12], as shown in Table 4
the study was found to be successful in relation to par-
ticipants receiving the intended intervention, outcome
measures being considered acceptable and appropriate
and being completed at the primary endpoint of the
study and the intervention being considered acceptable
and appropriate for use in a definitive trial. The study
was unsuccessful in relation to recruitment, practitioner
adherence to the protocol, completion of outcome mea-
sures at 1-month follow-up and blinding.
Discussion
The study did not meet its target of recruiting at least 2
participants per month or 20 participants in total. This
is not unusual and other studies have also reported re-
cruitment as being slower or more difficult than ex-
pected [28]. It has been suggested that clinical staff have
limited time to undertake research activities [29] and
this may have influenced the identification of potential
participants. A future trial would need to ensure that
trial centres allocated adequate time and personnel.
Potential participants should be provided with some
education about the intervention as a brief introduction
may make participants less sceptical and more willing to
Fig. 2 Box plot of ‘average pain’ intensity at baseline and day 28
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consent. Recruitment could be enhanced by a multi-
centred approach. Intensity of PLP was a major barrier
to recruitment. Although PLP can be severe, this may
only be in approximately 30 % of amputees [30, 31]
explaining why this inclusion criterion excluded nine
participants. Future studies may consider lowering or ex-
cluding the severity of this criterion.
The study did not meet its target of recruiting at least
70 % of all eligible participants. However, this criterion
was unrealistically high and 62.50 % of all eligible partic-
ipants were recruited. Other CAM studies report a lower
participation rate [32] and studies evaluating the
effectiveness of interventions for treating PLP also report
a lower participation rate [33]. This study may not have
met its target recruitment rate because it was set unreal-
istically high. Participation rate was good, suggesting
that a future trial would be possible.
Amputees have often undergone extensive unpleasant
interventions prior to amputation, and this may partly ex-
plain the reason for those refusing to consent. The study
site may not have been optimal for recruiting due to it be-
ing a busy unit providing rehabilitation care for those at a
key life point. Although, overall, recruitment was good, fu-
ture studies may benefit by including amputees who are
Table 2 Summary statistics at baseline and day 28 expressed as mean and between-group effect sizes








Number of participants who
provided complete data
Acupuncture 8 7
Usual care 7 5
NRS average pain Acupuncture 5.44 (3.90–6.98) 0.00 2.75 (0.31–5.19) 0.64
Usual care 5.43 (3.75–7.11) 4.43 (2.37–6.49)
NRS worst pain Acupuncture 8.00 (6.21–9.79) 0.38 4.00 (0.40–7.60) 0.69
Usual care 7.29 (5.80–8.77) 6.29 (4.54–8.03)
SF-MPQ-2 Acupuncture 2.55 (1.70–3.40) 0.21 1.06 (0.13–2.24) 0.46
Usual care 2.85 (1.22–4.47) 1.89 (0.07–3.85)
HADS anxiety Acupuncture 6.38 (2.75–10.00) 0.29 5.25 (1.97–8.53) 0.10
Usual care 5.29 (2.33–8.24) 4.86 (1.38–8.34)
HADS depression Acupuncture 6.63 (3.34–9.91) 0.35 0.35 5.75 (1.35–10.15) 0.12
Usual care 5.14 (0.99–9.29 5.14 (0.99–9.29)
PSS-10 Acupuncture 15.25 (10.90–19.60) 0.31 11.63 (5.43–17.82) 0.48
Usual care 17.28 (10.11–24.46) 15.57 (7.35–23.79)
ISI Acupuncture 13.50 (5.96–21.04) 0.49 8.50 (1.65–15.35) 0.14
Usual care 9.14 (0.93–17.35) 7.42 (0.61–14.24)
EQ-5D-5 L mobility Acupuncture 4.88 (4.58–5.17) 0.00 3.75 (2.88–4.62) 0.47
Usual care 4.88 (4.58–5.17) 4.29 (3.13–5.45)
EQ-5D-5 L self care Acupuncture 1.75 (1.16–2.34) 0.24 1.63 (1.00–2.25) 0.09
Usual care 1.57 (0.84–2.30) 1.57 (1.08–2.07)
EQ-5D-5 L usual activities Acupuncture 3.75 (2.68–4.82) 0.45 2.88 (2.18–3.57) 0.84
Usual care 4.29 (3.26–5.31) 3.71 (2.69–4.74)
EQ-5D-5 L pain-discomfort Acupuncture 3.50 (2.87–4.13) 1.24 2.88 (2.18–3.57) 0.44
Usual care 2.71 (2.26–3.17) 2.57 (2.08–3.07)
EQ-5D-5 L anxiety/depression Acupuncture 2.00 (1.11–2.89) 0.46 2.00 (1.23–2.77) 0.50
Usual care 1.57 (0.84–2.30) 1.57 (0.84–2.30)
EQ-5D-5 L health today Acupuncture 63.13 (46.41–79.84) 0.21 74.63 (58.49–90.76) 0.15
Usual care 67.14 (50.29–84.00) 77.14 (63.05–91.23)
PGIC Acupuncture 5.71 (4.23–7.20) 1.27
Usual care 3.20 (0.37–6.03)
CI confidence interval, EQ-5D-5 L EuroQol-5 dimensions, HADS Hospital Anxiety and Depression Scale, ISI Insomnia Severity Index, NRS numerical rating scale,
PGIC Patient Global Impression of Change, PSS-10 Perceived Stress Scale 10-item, SF-MPQ-2 Short Form McGill Pain Questionnaire 2
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not in an inpatient unit receiving multiple interventions at
a key life point and by making the proposed intervention
less intensive.
Blinding was unsuccessful. A future study may benefit
from clearly including information on the participant in-
formation sheet about the necessity of blinding and
should ensure that the outcome measures used are reli-
able and objective. Additionally, a future trial could use
duplicate assessments of outcomes and report the level
of agreement between assessors [34]. Also, different data
analysts to data collectors could be used.
Establishing acceptability and compliance to an inter-
vention is vital because if the intervention is unaccept-
able and participants are not compliant, the study will
fail. This study suggested that acupuncture and usual
care were acceptable and participants were compliant
with the protocol. Unlike usual care alone, acupuncture
did appear to be clinically effective at reducing pain in-
tensity and the findings suggested a ‘meaningful change’
[23]. This is in keeping with results from case studies
[11] and nonrandomised controlled trials [10]. Clinically
meaningful change is important as this is relevant to pa-
tient care. Across a diverse patient group a change of
1.74 on an 11-point NRS has been associated with ‘much
improved’ and a change of 2.76 ‘very much improved’
[35] suggesting that by the primary endpoint participants
in the acupuncture group average pain was ‘much im-
proved’ and worst pain was ‘very much improved’ but
this was not so in the usual care group for either average
or worst pain. In keeping with quantitative findings,
qualitatively acupuncture was perceived to be effective at
resolving symptoms. Findings from this study support
the need for a definitive trial to determine effectiveness.
As less than eight treatments may be effective this may
be a more appropriate and cost-effective dosage. A usual
care control should be used in future studies as it has
the advantage of being safe (physicians make individua-
lised treatment decisions about participant care) and,
unlike efficacy trials, ensures that the intervention can
claim to be superior to usual practice [36].
Unexpectedly, practitioners were found to not adhere
to the acupuncture protocol. This lack of adherence may
have been partly due to tensions between clinical and re-
search workload [29] and also due to poor communica-
tion with the research team. This would need addressing
before undertaking a future trial as lack of participants
receiving the full intervention as intended could lead to
reduced effectiveness, a decrease in study power and in-
appropriate conclusions [37]. Robiner [38] provides a
table of adherence-enhancing strategies which could be
used in a future trial, including: promoting collaboration
and good communication between acupuncturists and
research staff, providing feedback on adherence, promot-
ing nonjudgemental discussion around adherence, and
addressing adherence problems proactively.
Although adverse events were captured during semi-
structured interviews, practitioner compliance of capture
of adverse effects was poor. This is not uncommon [39]
but would need addressing before undertaking a defini-
tive trial. Recommendations of capture of adverse events
include capturing the frequency, incidence, timing, and
severity of each event [40]. A future study may benefit
from giving practitioners a log book designed to capture
this information.
The study identified appropriate outcome measures
which could be used in a future trial. However, as the
SF-MPQ-2 included some terminology which was not
understood, an alternative outcome measure may be
Table 3 Acupuncture group participant quotes from semistructured interviews
Theme Quote
Scepticism and lack of expectations ‘I was a bit worried about what it was all about. You said “acupuncture” and I said “I’m not keen on that”.
And then I thought I’ll try it, I’ll try it out.’ (Interviewee 1)
‘Didn’t expect it to work. Very, very, very sceptical me, very. That’s how ignorant I was… I didn’t think it
would work, I thought it was all nonsense.’ (Interviewee 4)
Being treated ‘It was so relaxing… and, um, I was just lying there and I could have quite easily gone to sleep! It was so
relaxing, so sort of peaceful.’ (Interviewee 2)
Changes in phantom limb pain ‘I said “well, it’s good. It’s very good…” It works good and then last time she came she said “aren’t you
going to have it?” I said “no, no, it’s got rid of that pain that was down there”.’ (Interviewee 1)
Factors affecting treatment ‘She (the acupuncturist) looked after you well and I think that was a lot of it, her personality and the way
she treated you and everything.’ (Interviewee 2)
‘I think because of the environment it was being done in and the timing more than anything, I think it
wasn’t really a positive thing. It might have been a different story in another setting, if I had more time
around my schedule.’ (Interviewee 3)
Completing the outcome measures (Re the SF-MPQ-2) ‘ A couple of the wordings were a bit weird. I didn’t get some of the words on the
describe the pain, gruelling and what was the other one? There were a couple of them I didn’t
understand what these words meant.’ (Interviewee 4)
A good experience ‘It’s been very positive… it’s been an extra benefit I would definitely say that… I couldn’t criticise
anything to be perfectly honest.’ (Interviewee 5)
SF-MPQ-2 Short Form McGill Pain Questionnaire 2
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more appropriate such as the neuropathic pain scale,
the neuropathic pain symptom inventory, or the Pain
Quality Assessment Scale [41, 42]. Although partici-
pants adhered to completing outcome measures, this
was not sustained post the primary endpoint of the
study. This lack of long-term retention needs address-
ing as poor retention has implications for statistical
power and the internal and external validity of a study
[43]. Strategies could be implemented such as including
a follow-up contact, prenotification reminders, and
mentioning an obligation to respond [44]. In rando-
mised controlled trials offering and giving small monet-
ary incentives has been found to be successful in
improving response [43]. However, lower limb ampu-
tees tend to be a frail population and long-term survival
post amputation is poor. By 1 year post amputation
almost half (44 %) of lower limb amputees will have
died and by 5 years 77 % [45]. Additionally, major am-
putations are associated with high morbidity and com-
plication rates. This would need to be taken into
consideration when designing a definitive trial.
Limitations
This study did not consider the effect of attention on
symptoms and did not include a control that mimicked
the theoretically inactive elements but not the active ele-
ments of acupuncture. Further research needs to be car-
ried out to identify optimal dosage, which aspects of
acupuncture intervention causes change and whether
environmental factors affect outcomes. The study did
not recruit the number of participants it initially aimed
to recruit and the quantitative findings reported in this
Table 4 Success of feasibility study
A priori criteria Findings Objective met?
(yes/no)
Recruitment rate was ≥2 participants per month fitting the
eligibility criteria
Recruitment rate was 1.36 eligible participants per month No
The study recruited ≥70 % of all eligible potential participants 62.50 % of all eligible participants were recruited No
Of the participants recruited to acupuncture group ≥90 %
received their first acupuncture treatment within 1 week of
recruitment
All participants received their first acupuncture treatment
within 1 week of recruitment
Yes
After randomisation and allocation ≥90 % of participants
received treatment as initially intended
All participants received treatment as intended and the study
protocol was considered acceptable
Yes
Of the participants recruited to acupuncture group ≥80 %
received all 8 acupuncture treatments
No participants received all 8 treatments (mean total number
of treatments 5.14 (4.02–6.27))
No
Of the participants recruited to usual care group ≤10 %
dropped out of the study
One participant (14.29 %) of participants dropped out of the
usual care group
No
At the primary endpoint of the study outcome measures
were completed by ≥90 % of participants
100 % of participants still enrolled on the study completed all
outcome measures by the primary endpoint of the study
Yes
At 1 month after completion of the study, outcome measures
were completed by ≥60 % of participants
Outcome measures were completed by 5 participants (33.33 %) No
Qualitative data identified that outcome measures were
acceptable and appropriate, that questionnaires and rating
scales were easy to complete and that outcome measures
could be identified for use in a definitive trial
Outcome measures were considered acceptable, appropriate
and easy to complete. The HADS, PSS-10, EQ-5D-5 L, and ISI
may not be appropriate for use in a definitive trial
Yes
Qualitative data implied that acupuncture was an acceptable
and effective intervention for treating PLP with or without
other secondary symptoms
Acupuncture/electroacupuncture was considered acceptable.
Acupuncture was perceived to be effective at treating both
PLP and other secondary complaints
Yes
Data were collected on the primary outcome measure (NRS)
and effect size was calculated to inform a sample size
calculation for a larger trial
Considering a 20 % dropout rate, 170 participants are
recommended to be recruited to detect a significant change
in a two-armed, parallel-group randomised controlled trial
comparing usual care and acupuncture as measured using an
11-point NRS measuring average pain at 4 weeks
Yes
Qualitative and quantitative data implied that the
acupuncture protocol used in the feasibility study was
appropriate for use in a definitive multicentred
randomised controlled trial
Participants did not drop out of the acupuncture group
suggesting that it was acceptable. Participants’ symptoms
generally improved over 6 treatments suggesting that 8
treatments was adequate. Acupuncture and electroacupuncture
were considered acceptable, effective, and relaxing
Yes
The researcher was not aware which group participants
had been enrolled to 100 % of the time
Blinding was not successful and the researcher knew through
both participants and clinical staff at the amputee unit their
group allocation
No
EQ-5D-5 L EuroQol-5 dimensions, HADS Hospital Anxiety and Depression Scale, ISI Insomnia Severity Index, NRS numerical rating scale, PSS-10 Perceived Stress
Scale 10-item, SF-MPQ-2 Short Form McGill Pain Questionnaire 2
Trevelyan et al. Trials  (2016) 17:519 Page 9 of 11
study should be interpreted with caution. Only one prac-
titioner was involved in this study and as differences in
effectiveness are known to occur with different practi-
tioners [46] future studies would benefit from the use of
multiple practitioners. Practitioners did not adhere to
the acupuncture protocol and participants were not of-
fered eight treatments, making it difficult to determine
the effectiveness of the protocol. Two participants in the
acupuncture group were not interviewed and data satur-
ation of qualitative data cannot be assumed.
Conclusions
The study provides novel data on the feasibility of con-
ducting a randomised controlled trial to establish the
effectiveness of acupuncture for treating lower limb am-
putees with PLP. The study identified that acupuncture
may cause clinically meaningful change. The protocol
used in this study was acceptable and data on effect size
were generated allowing for a sample size calculation.
Areas which would need addressing prior to undertaking
a definitive trial were identified.
Additional files
Additional file 1: CONSORT 2010 checklist of information to include
when reporting a randomised trial. (PDF 144 kb)
Additional file 2: Acupuncture points used by practitioners during the
feasibility study. (PDF 84 kb)
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